PM

Professor McBain

Rhinomed Limited | Non-Executive Director
Prof McBain is the former Head of the Endocrine and Metabolic Service, Director of Surgical Services then Head of Reproductive Services spanning 1998-2019 at The Royal Womens Hospital, Melbourne, he was also a founder and then Chairman of Melbourne IVF, now part of Virtus Health. He is a former president of the Fertility Society of Australia. In 1978, John wrote the first Australian Report into AID, which demonstrated the non-inferiority of frozen donor semen over fresh. In 2013, John was made an Officer in the Order of Australia (AO) for his contribution to reproductive medicine and his distinguished service as a gynaecologist, as an academic in medical education, and his contribution to professional organisations. John has almost 30 years experience in investing in and supporting early stage companies. He was a non-executive director of Touch Ventures Limited (ASX:TVL), Simavita Limited (ASX:SVA) and Rhinomed Limited (ASX:RNO).

Companies and Roles

Company
Title
Tenure
Since
RNO
Rhinomed Limited
  • Non-Executive Director
4yrsMay 2021
VFY
Vitrafy Life Sciences Limited
  • Non-Executive Director
4yrs, 9mthAug 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
VFY
Vitrafy Life Sciences Limited
18/03/25N/A1,947,217175,000N/A
31/12/23N/A14,014,914N/AN/A
RNO
Rhinomed Limited
29/09/23N/A52,917,490N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
VFY
Vitrafy Life Sciences Limited
18/03/25
Buy
28,255$1.360$38,435On-market trade
VFY
Vitrafy Life Sciences Limited
10/12/24
Buy
27,500$1.799$49,461On-market trade
RNO
Rhinomed Limited
05/09/23
Buy
100,000$0.070$7,000On-market trade
RNO
Rhinomed Limited
05/09/23
Buy
100,000$0.070$7,000On-market trade.
RNO
Rhinomed Limited
19/04/22
Issued
4,868,214$0.190$924,961Rights issue